| For: | Zhou J, Chng WJ. Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies. World J Clin Oncol 2018; 9(5): 90-97 [PMID: 30254964 DOI: 10.5306/wjco.v9.i5.90] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v9/i5/90.htm |
| Number | Citing Articles |
| 1 |
Xianwen Yang, Molly Pui Man Wong, Ray Kit Ng. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications. International Journal of Molecular Sciences 2019; 20(18) doi: 10.3390/ijms20184576
|
| 2 |
Motoki Eguchi, Yosuke Minami, Ayumi Kuzume, SungGi Chi. Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia. Biomedicines 2020; 8(8) doi: 10.3390/biomedicines8080245
|
| 3 |
Muhammad Usama Tariq. 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine. 2020; doi: 10.1007/978-981-15-1067-0_3
|
| 4 |
Iuliana Iordan, Anca Nicolescu, Irina Voican, Minodora Onisâi, Ana Maria Vlădăreanu. FLT3-positive acute myeloid leukemia: an example of personalized approach. Oncolog-Hematolog.ro 2020; 4(53) doi: 10.26416/OnHe.53.4.2020.4045
|
| 5 |
Wolf‐Karsten Hofmann, Andreas Trumpp, Carsten Müller‐Tidow. Therapy resistance mechanisms in hematological malignancies. International Journal of Cancer 2023; 152(3) doi: 10.1002/ijc.34243
|
| 6 |
Mohamed Abdelsalam, Melisa Halilovic, Ramy Ashry, Husam Nassar, Frank Erdmann, Matthias Schmidt, Oliver H. Krämer, Wolfgang Sippl. Dual FLT3/MAPK14 Proteolysis-Targeting Chimera (PROTAC) Induces Potent Acute Myeloid Leukemia Cell Death. Pharmaceuticals 2026; 19(5) doi: 10.3390/ph19050756
|
| 7 |
Maëlle Cartel, Pierre-Luc Mouchel, Mathilde Gotanègre, Laure David, Sarah Bertoli, Véronique Mansat-De Mas, Arnaud Besson, Jean-Emmanuel Sarry, Stéphane Manenti, Christine Didier. Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy. Leukemia 2021; 35(2) doi: 10.1038/s41375-020-0878-x
|
| 8 |
Yi Xu, Kimberly Payne, Linh Hoang Gia Pham, Park Eunwoo, Jeffrey Xiao, David Chi, Justin Lyu, Rosalia Campion, Samiksha Wasnik, Il Seok Jeong, Xiaolei Tang, David Jeston Baylink, Chien Shing Chen, Mark Reeves, Mojtaba Akhtari, Saied Mirshahidi, Guido Marcucci, Huynh Cao. A novel vitamin D gene therapy for acute myeloid leukemia. Translational Oncology 2020; 13(12) doi: 10.1016/j.tranon.2020.100869
|
| 9 |
Amin Huang, Peiting Zeng, Yinguang Li, Wenhua Lu, Yaoming Lai. LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.782065
|
| 10 |
Eman M.E. Dokla, Amal Kamal Abdel-Aziz, Sandra N. Milik, Martin J. McPhillie, Saverio Minucci, Khaled A.M. Abouzid. Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia. Bioorganic & Medicinal Chemistry 2022; 56 doi: 10.1016/j.bmc.2021.116596
|
| 11 |
Cristina Papayannidis, Chiara Sartor, Giovanni Marconi, Maria Chiara Fontana, Jacopo Nanni, Gianluca Cristiano, Sarah Parisi, Stefania Paolini, Antonio Curti. Acute Myeloid Leukemia Mutations: Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(11) doi: 10.3390/ijms20112721
|
| 12 |
Yimin Zhou, Zhenfei Zhong, Peng Hu, Weigang Wang, Ying Song, Na Yang, Fangyan He, Yajie Li, Qi Sa, Yanmei Yang, Qinmiao Sun, Tonghua Yang, Beibei Zhang, Dahua Chen. Chronic ER Stress Triggers Cell‐Surface Chaperones as the Therapeutic Targets of CAR Cells in Acute Myeloid Leukemia. Advanced Science 2026; 13(5) doi: 10.1002/advs.202511573
|
| 13 |
Luyao Long, Yehuda G. Assaraf, Zi-Ning Lei, Hongwei Peng, Lin Yang, Zhe-Sheng Chen, Simei Ren. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia. Drug Resistance Updates 2020; 52 doi: 10.1016/j.drup.2020.100703
|
| 14 |
Bo-Reum Kim, Seung-Hyun Jung, A-Reum Han, Gyeongsin Park, Hee-Je Kim, Bin Yuan, Venkata Lokesh Battula, Michael Andreeff, Marina Konopleva, Yeun-Jun Chung, Byung-Sik Cho. CXCR4 Inhibition Enhances Efficacy of FLT3 Inhibitors in FLT3-Mutated AML Augmented by Suppressed TGF-β Signaling. Cancers 2020; 12(7) doi: 10.3390/cancers12071737
|
| 15 |
Aki Fujii-Hanamoto, Hirokazu Tanaka, Ko Fujimoto, Takahiro Haeno, Yoshiaki Miyake, Ryosuke Fujiwara, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, Hitoshi Hanamoto, Shinya Rai, Itaru Matsumura. Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells. Current Issues in Molecular Biology 2025; 47(10) doi: 10.3390/cimb47100797
|
| 16 |
Adrián Mosquera Orgueira, Laura Bao Pérez, Alicia Mosquera Torre, Andrés Peleteiro Raíndo, Miguel Cid López, José Á. Díaz Arias, Roi Ferreiro Ferro, Beatriz Antelo Rodríguez, Marta S. González Pérez, Manuel Albors Ferreiro, Natalia Alonso Vence, Manuel M. Pérez Encinas, José L. Bello López, Giovanni Martinelli, Claudio Cerchione. FLT3 inhibitors in the treatment of acute myeloid leukemia: current status and future perspectives. Minerva Medica 2020; 111(5) doi: 10.23736/S0026-4806.20.06989-X
|
| 17 |
Jiali Zhu, Tao Yang, Minghai Tang, Zhuang Yang, Heying Pei, Haoyu Ye, Yu Tang, Zhixuan Cheng, Ping Lin, Lijuan Chen. Studies on the anti-psoriasis effects and its mechanism of a dual JAK2/FLT3 inhibitor flonoltinib maleate. Biomedicine & Pharmacotherapy 2021; 137 doi: 10.1016/j.biopha.2021.111373
|
| 18 |
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, Jimma Lenjisa, Alemwork Kebede, Yi Long, Gary Heinemann, Jasmine Karanjia, Benjamin Noll, Sunita K. C. Basnet, Manjun Li, Robert Milne, Hugo Albrecht, Shudong Wang. An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers 2022; 14(5) doi: 10.3390/cancers14051113
|
| 19 |
Joshua J. Lara, Alfonso E. Bencomo-Alvarez, Mayra A. Gonzalez, Idaly M. Olivas, James E. Young, Jose L. Lopez, Vanessa V. Velazquez, Steven Glovier, Mehrshad Keivan, Andres J. Rubio, Sara K. Dang, Jonathan P. Solecki, Jesse C. Allen, Desiree N. Tapia, Boranai Tychhon, Gonzalo E. Astudillo, Connor Jordan, Darshan S. Chandrashekar, Anna M. Eiring. 19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML). International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232314586
|